Teva's Bid To Crack Attorney-Client Privilege Fails
A federal judge has denied Teva Pharmaceuticals USA Inc.'s bid to force a Merck & Co. Inc. affiliate to produce privileged documents related to Merck's alleged fraud in obtaining the patent...To view the full article, register now.
Already a subscriber? Click here to view full article